Evidence map›Paper›PMID 26090072›Full record

ArticleOxidative medicine and cellular longevity2015

Integrated Haematological Profiles of Redox Status, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome.

Carla Lubrano, Giuseppe Valacchi, Palma Specchia, Lucio Gnessi, Elizaveta P Rubanenko, Elena A Shuginina, Arseny I Trukhanov, Liudmila G Korkina, Chiara De Luca

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. FermentedNutrients · 2022
    Trial
  2. Trial
  3. Article
  4. Effects of Heavy Isotopes (Sports (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Oxidative medicine and cellular longevity · 2017
    Article
  11. Article
  12. Effects of iron supplementation in mice with hypoferremia induced by obesity.Experimental biology and medicine (Maywood, N.J.) · 2016
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Carla LubranoSection of Medical Pathophysiology, Endocrinology and Food Science, Department of Experimental Medicine, "Sapienza" University, "Umberto I" Polyclinic, Viale Regina Elena 324, 00161 Rome, Italy.
Giuseppe ValacchiDepartment of Life Sciences and Biotechnology, University of Ferrara, Via Luigi Borsari 46, 44100 Ferrara, Italy ; Department of Food and Nutrition, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of Korea.
Palma SpecchiaSection of Medical Pathophysiology, Endocrinology and Food Science, Department of Experimental Medicine, "Sapienza" University, "Umberto I" Polyclinic, Viale Regina Elena 324, 00161 Rome, Italy.
Lucio GnessiSection of Medical Pathophysiology, Endocrinology and Food Science, Department of Experimental Medicine, "Sapienza" University, "Umberto I" Polyclinic, Viale Regina Elena 324, 00161 Rome, Italy.
Elizaveta P RubanenkoActive Longevity Clinic "Institut Krasoty na Arbate", 8 Maly Nikolopeskovsky Lane, Moscow 119002, Russia.
Elena A ShugininaActive Longevity Clinic "Institut Krasoty na Arbate", 8 Maly Nikolopeskovsky Lane, Moscow 119002, Russia.
Arseny I TrukhanovActive Longevity Clinic "Institut Krasoty na Arbate", 8 Maly Nikolopeskovsky Lane, Moscow 119002, Russia.
Liudmila G KorkinaActive Longevity Clinic "Institut Krasoty na Arbate", 8 Maly Nikolopeskovsky Lane, Moscow 119002, Russia ; Centre of Innovative Biotechnological Investigations (Cibi-NanoLab), 197 Vernadskogo Prospekt, Moscow 119571, Russia.
Chiara De LucaCentre of Innovative Biotechnological Investigations (Cibi-NanoLab), 197 Vernadskogo Prospekt, Moscow 119571, Russia.
Policlinico Umberto I · ITKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of obesity (OB) and metabolic syndrome (MetS) implies free radical-, oxidized lipid- (LOOH-), and inflammatory cytokine-mediated altered pathways in target organs. Key elements of the transition from benign OB to unhealthy OB+MetS remain unclear. Here, we measured a panel of redox, antioxidant, and inflammation markers in the groups of OB patients (67 with, 45 without MetS) and 90 controls. Both OB groups displayed elevated levels of adipokines and heavy oxidative stress (OS) evidenced by reduced levels of glutathione, downregulated glutathione-S-transferase, increased 4-hydroxynonenal-protein adducts, reactive oxygen species, and membrane-bound monounsaturated fatty acids (MUFA). Exclusively in OB+MetS, higher-than-normal glutathione peroxidase activity, tumor necrosis factor-α, and other proinflammatory cytokines/chemokines/growth factors were observed; a combination of high adipokine plasminogen activator inhibitor-1 and MUFA was consistent with increased cardiovascular risk. The uncomplicated OB group showed features of adaptation to OS such as decreased levels of vitamin E, activated superoxide dismutase, and inhibited catalase, suggesting H2O2 hyperproduction. Proinflammatory cytokine pattern was normal, except few markers like RANTES, a suitable candidate for therapeutic approaches to prevent a setting of MetS by inhibition of LOOH-primed leukocyte chemotaxis/recruitment to target tissues.

Indexed as

Adenosine TriphosphateAdipokinesAdultAntioxidantsBiomarkersCohort StudiesCytokinesErythrocytesFatty AcidsFemaleHumansMaleMetabolic SyndromeMiddle AgedObesityOxidative StressAdenosine TriphosphateAdipokinesAntioxidantsBiomarkersCytokinesFatty Acids

Identifiers

PMID26090072
PMCPMC4451994
OpenAlexW1490074812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.